- Medicine Name: Ajovy
- Generic Name: Fremanezumab-vfrm
- Dosage Form & Strength: Injections: 225 mg/1.5 mL
- Manufactured By: Teva Pharmaceuticals, Inc.
Ajovy (fremanezumab-vfrm) is a calcitonin gene-related peptide (CGRP) antagonist used for the preventive treatment of migraine in adults.
Recommended Dosage: The recommended dosage of Ajovy is administered by subcutaneous injection into areas of the abdomen, thigh, or upper arm that are not bruised, tender, red, or indurated. For more than one injection, the same body site can be considered, but not the exact location of the previous injection.
Two subcutaneous (SC) dosing options of Ajovy are available to administer the recommended dosage:
- 225 mg monthly, or
- 675 mg every three months (quarterly), which is administered as 3 consecutive subcutaneous (SC) injections of 225 mg each.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.